Today’s decision is a big win for patients in the fight against the pharmaceutical industry’s greed!
The Supreme Court declined petitions from AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim challenging the Medicare Drug Price Negotiation Program – letting lower court rulings stand that will let the program move forward and continue delivering relief to patients.
It’s US vs. pharma, and today, patients won!